These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8339386)

  • 1. Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor.
    MacDonald JR; Pegg DG
    Cancer Chemother Pharmacol; 1993; 32(5):365-7. PubMed ID: 8339386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidote studies of vinorelbine-induced skin ulceration in the mouse.
    Dorr RT; Bool KL
    Cancer Chemother Pharmacol; 1995; 36(4):290-2. PubMed ID: 7628047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agent.
    Rowinsky EK; Long GS; Noe DA; Grochow LB; Bowling MK; Sartorius SE; Donehower RC
    Clin Cancer Res; 1997 Mar; 3(3):401-7. PubMed ID: 9815698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas.
    Patel SR; Burgess MA; Papadopolous NE; Sidhu G; Gray R; Plager C; Jenkins J; Benjamin RS
    Invest New Drugs; 1998; 16(1):87-92. PubMed ID: 9740549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity.
    Pazdur R; Meyers C; Diaz-Canton E; Abbruzzese JL; Patt Y; Grove W; Ajani J
    Am J Clin Oncol; 1997 Dec; 20(6):573-6. PubMed ID: 9391543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal carboplatin and ifosfamide extravasation in the mouse.
    Marnocha RS; Hutson PR
    Cancer; 1992 Aug; 70(4):850-3. PubMed ID: 1643617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extravasation of chemotherapeutic agents.
    Hankin FM; Louis DS
    Am Fam Physician; 1985 Mar; 31(3):147-50. PubMed ID: 3976457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group study.
    Whitehead RP; Unger JM; Flaherty LE; Eckardt JR; Taylor SA; Didolkar MS; Samlowski W; Sondak VK
    Invest New Drugs; 2001; 19(3):239-43. PubMed ID: 11561681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.
    Rudolph R; Larson DL
    J Clin Oncol; 1987 Jul; 5(7):1116-26. PubMed ID: 3298560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
    Dorr RT; Snead K; Liddil JD
    Cancer; 1996 Jul; 78(1):152-6. PubMed ID: 8646711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between subcutaneous steroid injection for extravasation of vesicant anticancer drugs and skin ulcers requiring surgery.
    Ohisa K; Yamana H; Morita K; Matsui H; Fushimi K; Yasunaga H
    Eur J Oncol Nurs; 2022 Jun; 58():102119. PubMed ID: 35358899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidotes to vesicant chemotherapy extravasations.
    Dorr RT
    Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes.
    Elam EA; Dorr RT; Lagel KE; Pond GD
    Invest Radiol; 1991 Jan; 26(1):13-6. PubMed ID: 2022447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin and perivascular toxicity induced experimentally by doxorubicin.
    Balsari A; Lombardo N; Ghione M
    J Chemother; 1989 Oct; 1(5):324-9. PubMed ID: 2585034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extravasation of dactinomycin, vincristine, and cisplatin: studies in an animal model.
    Buchanan GR; Buchsbaum HJ; O'Banion K; Gojer B
    Med Pediatr Oncol; 1985; 13(6):375-80. PubMed ID: 4046975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone.
    Dorr RT; Alberts DS; Soble M
    Cancer Chemother Pharmacol; 1986; 16(2):91-4. PubMed ID: 3948308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment methods for extravasations of chemotherapeutic agents: a comparative study.
    Loth TS; Eversmann WW
    J Hand Surg Am; 1986 May; 11(3):388-96. PubMed ID: 3711613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicant extravasation: myths and realities.
    Boyle DM; Engelking C
    Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.